Publications by authors named "Ramos-Sanchez Monica"
Dilated cardiomyopathy (DCM) encompasses various acquired or genetic diseases sharing a common phenotype. The understanding of pathogenetic mechanisms and the determination of the functional effects of each etiology may allow for tailoring different therapeutic strategies. MicroRNAs (miRNAs) have emerged as key regulators in cardiovascular diseases, including DCM.
View Article and Find Full Text PDFArticle Synopsis
- The study focused on analyzing cardiological complications in elderly patients (≥75 years) hospitalized due to COVID-19, tracking their health outcomes from March to May 2020.
- It involved 305 patients, mostly elderly women, with significant pre-existing heart conditions; during hospitalization, there were high rates of complications, with 36.7% of patients dying.
- Over a 12-month follow-up, cardiovascular issues persisted, highlighting congestive heart failure (CHF) as the most common complication, indicating that elderly patients with COVID-19 face significant cardiac risks leading to extended hospital stays.
Article Synopsis
- Dilated cardiomyopathy (DCM) is a serious heart disease that makes the heart's chambers larger and weaker, affecting how well it pumps blood.
- It is important to figure out what causes DCM early on so doctors can help patients better, but understanding the disease can be difficult.
- Researchers are looking into tiny molecules called microRNAs (miRNAs) that might help doctors diagnose and treat DCM without invasive procedures, but more studies are needed to confirm their usefulness.